APA (7th ed.) Citation

A, G., T, L., AD, H., V, D., T, D., T, C., . . . JS, F. (2026). Rifamycin Structural Modifications Attenuate PXR Binding and CYP3A4 Induction. Journal of medicinal chemistry, 69(13), 15858. https://doi.org/10.1021/acs.jmedchem.6c00944

Chicago Style (17th ed.) Citation

A, George, Lan T, Huber AD, Dartois V, Dick T, Chen T, Aldrich CC, and Freundlich JS. "Rifamycin Structural Modifications Attenuate PXR Binding and CYP3A4 Induction." Journal of Medicinal Chemistry 69, no. 13 (2026): 15858. https://doi.org/10.1021/acs.jmedchem.6c00944.

MLA (9th ed.) Citation

A, George, et al. "Rifamycin Structural Modifications Attenuate PXR Binding and CYP3A4 Induction." Journal of Medicinal Chemistry, vol. 69, no. 13, 2026, p. 15858, https://doi.org/10.1021/acs.jmedchem.6c00944.